Blood News and Research

RSS

New research on phagocytosis and SARS-CoV-2's spike protein

A new study showed that convalescent patient plasma and monoclonal anti-spike antibodies were able to induce phagocytosis at high antibody concentrations.

20 Oct 2021

Biomarker predicts severity of SARS-CoV-2 infection in patients

A new study investigates a biomarker to predict the severity of disease in patients infected with SARS-CoV-2.

20 Oct 2021

U-M study receives $13 million grant to track cancer risk from environmental exposures

Heavy metals like lead, industrial pollution from steel mills, coal-fired power plants or oil refineries, “forever chemicals” called PFAS that don’t break down in the environment—how much are Michigan residents exposed to these environmental contaminants and what does this mean for their risk of developing cancer?

20 Oct 2021

Scientists search for cause of mysterious covid-related inflammation in children

Like most other kids with covid, Dante and Michael DeMaino seemed to have no serious symptoms.

20 Oct 2021

Research uncovers a new human sensory ability to detect sugars in the mouth

Most everyone understands that a major role of our sense of taste is to inform us when sugar is present in foods and beverages by eliciting sweetness on our tongues. A study led by the Monell Chemical Senses Center, published this month in PLOS ONE, identifies a new human sensory ability to detect sugars in the mouth with a molecular calorie detector, of sorts.

20 Oct 2021

Researchers identify new gene variants that may cause inherited retinal dystrophies

An international team of researchers, led by scientists at University of California San Diego and Shiley Eye Institute at UC San Diego Health, has broadened and deepened understanding of how inherited retinal dystrophies (IRDs) affect different populations of people and, in the process, have identified new gene variants that may cause the diseases.

20 Oct 2021

Collaborations and co-achievements of network of COST Actions on COVID-19

Addressing societal issues by enabling cross-disciplinary partnerships is an inherent part of a COST Actions' nature. But collaborations don't stop at the gate of these specific networks: multiple COST Actions have joined forces since the beginning of the pandemic to help advance research into COVID-19.

20 Oct 2021

Infrared light therapy may potentially benefit people with dementia

Infrared light therapy might have the potential to help people living with dementia, according to researchers.

19 Oct 2021

Research reveals troubling implications for female teenagers with obesity and chronic pain

New research on obesity and chronic pain in adolescents uncovers sex differences with troubling implications for female teenagers with these conditions.

19 Oct 2021

New AI-based computer algorithm may enable quicker diagnosis of heart failure

A special artificial intelligence (AI)-based computer algorithm created by Mount Sinai researchers was able to learn how to identify subtle changes in electrocardiograms (also known as ECGs or EKGs) to predict whether a patient was experiencing heart failure.

19 Oct 2021

New findings may help widen therapeutic interventions for B-cell acute lymphoblastic leukemia

A retrospective study led by Northwestern Medicine investigators found that the chimeric antigen receptor (CAR) T-cell immunotherapy drug tisagenlecleucel demonstrated safety and efficacy in pediatric patients with relapsed and refractory B-cell acute lymphoblastic leukemia (B-cell ALL), even when the drug doesn't meet the FDA's strict manufacturing standards.

19 Oct 2021

Millets can play a promising role in preventing and reducing iron deficiency anemia, study shows

A new study has shown that regular consumption of millets can improve hemoglobin and serum ferritin levels to reduce iron deficiency anemia, which is rising globally.

19 Oct 2021

Commonly prescribed medications can make the flu virus more or less active

Although the influenza virus varies a lot from year to year, the flu usually contributes to approximately 1000 deaths a year in Norway.

19 Oct 2021

COVID-19 vaccine breakthrough infections among immunocompromised individuals

A study of breakthrough infections in immunocompromised people following two doses of the Pfizer/BioNTech vaccine against SARS-CoV-2 concluded that immunocompromised people would be best served with a third dose of the vaccine for better protection.

19 Oct 2021

Living in socially vulnerable counties may increase risk of premature cardiovascular disease death

Americans who live in counties deemed "socially vulnerable" based on census variables are more likely to die from cardiovascular disease before age 65, according to new research published today in the American Heart Association's flagship journal Circulation.

19 Oct 2021

Scientists scan 110 natural compounds for SARS-CoV-2 antiviral potential

Phytochemicals are plant-derived molecules from medicinal plants that act as a prominent reservoir for treating a wide range of viral infections. In a new study, published in the journal Scientific Reports, scientists adopted a computational approach to identify Mpro inhibitors.

19 Oct 2021

Professor Liston’s latest book helps young children to learn about vaccines

The Professor Adrian Liston, Senior Group Leader at the Babraham Institute, and artist Dr Sonia Agüera-Gonzalez have published a captivating story book to teach children about the immune system and why vaccinations are important.

19 Oct 2021

SARS-CoV-2 antibodies detected in breast milk of vaccinated mothers

Now, a new medRxiv* preprint study finds mothers vaccinated either one of the messenger RNA (mRNA) vaccines transferred neutralizing antibodies and cytokines, including interferon-gamma (IFNγ), to a breastfeeding child. Additionally, the humoral response in breastmilk was effective in neutralizing four variants of concern.

18 Oct 2021

Blood pressure regulation in males and females is different, scientists say

Another difference between females and males appears to be a key mechanism in how they become hypertensive, scientists say, and consequently which antihypertensives should be most effective for them.

18 Oct 2021

Factors contributing to a weak antibody response to the Pfizer COVID-19 vaccine

A new study discusses risk factors for the failure of seroconversion following full vaccination with the COVID-19 Pfizer vaccine.

18 Oct 2021

Blood News and Research

New research on phagocytosis and SARS-CoV-2's spike protein

Biomarker predicts severity of SARS-CoV-2 infection in patients

U-M study receives $13 million grant to track cancer risk from environmental exposures

Scientists search for cause of mysterious covid-related inflammation in children

Research uncovers a new human sensory ability to detect sugars in the mouth

Researchers identify new gene variants that may cause inherited retinal dystrophies

Collaborations and co-achievements of network of COST Actions on COVID-19

Infrared light therapy may potentially benefit people with dementia

Research reveals troubling implications for female teenagers with obesity and chronic pain

New AI-based computer algorithm may enable quicker diagnosis of heart failure

New findings may help widen therapeutic interventions for B-cell acute lymphoblastic leukemia

Millets can play a promising role in preventing and reducing iron deficiency anemia, study shows

Commonly prescribed medications can make the flu virus more or less active

COVID-19 vaccine breakthrough infections among immunocompromised individuals

Living in socially vulnerable counties may increase risk of premature cardiovascular disease death

Scientists scan 110 natural compounds for SARS-CoV-2 antiviral potential

Professor Liston’s latest book helps young children to learn about vaccines

SARS-CoV-2 antibodies detected in breast milk of vaccinated mothers

Blood pressure regulation in males and females is different, scientists say

Factors contributing to a weak antibody response to the Pfizer COVID-19 vaccine

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News